-
A WEEK-IN-REVIEW FEATURED
REPORT
POSTER
The
Safety of Tenofovir DF for the Treatment of HIV Infection: The First 4 Years
M Nelson, D Cooper, R Schooley, et al
PDF Poster
Abstract
-
A
48-week Study of Tenofovir or Lamivudine or a Combination of Tenofovir and
Lamivudine
for the
Treatment of Chronic Hepatitis B in HIV/HBV-co-infected Individuals
M Nelson, S Bhagani, M
Fisher, et al
">
Abstract
-
Effect
of Tenofovir Disoproxil Fumarate-containing HAART on Bone Mineral Density in
HIV-infected Children
R Gafni, R Hazra, J
Reynolds, et al
Abstract
-
K65R,
L74V and Thymidine Analog Mutations in HIV-1 RT Associated with Reduced
Response to
Tenofovir DF in ART-experienced Patients
J Waters, N Margot, D
McColl, et al
Abstract
-
Rapid
Emergence of Drug-resistant SIV in Tenofovir-treated Macaques: Implications
for Tenofovir
Chemoprophylaxis against HIV
J Johnson, K Van Rompay, E
Delwart, W Heneine
Abstract
-
POSTER
A Pharmacologic
Basis for the Use of Tenofovir In Pre- and Post-exposure Prophylaxis: Intra-
and Extracellular Genital Tract Pharmacokinetics and Pharmacodynamics from
First Dose to
Steady State in HIV-1-infected Men and Women
M Vourvahis, H Tappouni, K
Patterson, et al
PDF Poster
Abstract
-
Prevention of Rectal SHIV Transmission in Macaques by Tenofovir/FTC
Combination
J Garcia-Lerma, R Otten, S
Qari, et al
Abstract
-
Differences in Calculated Glomerular Filtration Rates in Efavirenz- or
Tenofovir-treated
Adults
in ESS40006
M Thompson, R Haubrich D
Margolis, et al
Abstract
- Improvement
in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in
HIV-infected Children and Adolescents Switched from Stavudine to Tenofovir
A Viganò, P Brambilla, L Cafarelli. et al
Abstract
-
Didanosine and Lower Baseline Body Weight Are Associated with Declining Renal
Function
among Patients Receiving Tenofovir
H Crane, R Harrington, S Van Rompaey, M Kitahata
Abstract
-
Randomized Intensification of a Triple Nucleoside Regimen with Efavirenz or
Tenofovir in
ACTG
5095
R Gulick, C Lalama, C Shikum, et al
Abstract
-
Renal
Impairment Associated with the Use of Tenofovir
J Heffelfinger, D Hanson, A Voetsch, et al
Abstract
-
Molecular Mechanism of Tenofovir, Abacavir, and Lamivudine Resistance by the
K70E
Mutation in HIV-1 Reverse Transcriptase
Ni Sluis-Cremer, P Argoti Torres, J Grzybowski
Abstract
-
Tenofovir-induced Nephrotoxicity in the First Year of Therapy
J Guest,
D Rimland, B Patterson, K Desilva
Abstract
-
Use Of Tenofovir Plus Didanosine Backbone In HIV-Infected Subjects Failing
HAART
Bongiovanni M.,
Chiesa E., Cernat R, et al
Abstract
|